Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Novocal Strong is a combination nutraceutical softgel capsule developed and marketed by Captab Biotec. It is formulated for orthopedic health, specifically to support bone density, joint care, and to manage or prevent calcium and vitamin deficiencies. The combination contains calcitriol (active vitamin D3), calcium carbonate, vitamin K2-7, mecobalamin (methylcobalamin), zinc, magnesium, and L-methylfolate. Calcitriol enhances calcium absorption from the gut, while calcium carbonate directly replenishes bone mineral density. Vitamin K2-7 assists in directing calcium to the bones and teeth rather than soft tissues by activating osteocalcin. Mecobalamin and L-methylfolate support nerve health and reduce homocysteine levels, and zinc and magnesium serve as essential mineral cofactors for bone mineralization and enzymatic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Novocal Strong.